Rep. Byron Donalds Sells Chemed Co. (NYSE:CHE) Shares

Representative Byron Donalds (R-Florida) recently sold shares of Chemed Co. NYSE: CHE. In a filing disclosed on April 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Chemed stock on March 6th. The trade occurred in the Representative's "MORAN WEALTH IRA" account.

Representative Byron Donalds also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of DoorDash NASDAQ: DASH on 3/20/2025.
• Sold $1,001 - $15,000 in shares of GoDaddy NYSE: GDDY on 3/20/2025.
• Purchased $1,001 - $15,000 in shares of Arista Networks NYSE: ANET on 3/20/2025.
• Sold $1,001 - $15,000 in shares of Robinhood Markets NASDAQ: HOOD on 3/20/2025.
• Purchased $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 3/20/2025.
• Sold $1,001 - $15,000 in shares of Gartner NYSE: IT on 3/20/2025.
• Purchased $1,001 - $15,000 in shares of Chipotle Mexican Grill NYSE: CMG on 3/20/2025.
• Sold $1,001 - $15,000 in shares of Equifax NYSE: EFX on 3/20/2025.
• Purchased $1,001 - $15,000 in shares of Tradeweb Markets NASDAQ: TW on 3/20/2025.
• Sold $1,001 - $15,000 in shares of JPMorgan Chase & Co. NYSE: JPM on 3/20/2025.

Chemed Price Performance

Shares of NYSE:CHE traded up $16.67 on Tuesday, hitting $580.29. 42,713 shares of the company's stock were exchanged, compared to its average volume of 97,725. The stock has a market capitalization of $8.48 billion, a price-to-earnings ratio of 29.30, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61. The business's 50 day simple moving average is $586.59 and its two-hundred day simple moving average is $567.32.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed's payout ratio is 10.05%.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the transaction, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. This trade represents a 0.97 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 3.32% of the company's stock.

Wall Street Analyst Weigh In

CHE has been the topic of a number of research reports. Royal Bank of Canada raised their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Hedge Funds Weigh In On Chemed

A number of hedge funds and other institutional investors have recently modified their holdings of the business. UMB Bank n.a. grew its stake in Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Atala Financial Inc purchased a new stake in shares of Chemed during the fourth quarter valued at $29,000. CBIZ Investment Advisory Services LLC increased its position in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after acquiring an additional 22 shares during the period. Whipplewood Advisors LLC raised its stake in Chemed by 54.5% in the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock worth $31,000 after acquiring an additional 18 shares during the last quarter. Finally, Trust Co. of Vermont purchased a new stake in Chemed during the 4th quarter valued at about $34,000. 95.85% of the stock is currently owned by institutional investors.

About Representative Donalds

Byron Donalds (Republican Party) is a member of the U.S. House, representing Florida's 19th Congressional District. He assumed office on January 3, 2021. His current term ends on January 3, 2027. Donalds (Republican Party) is running for re-election to the U.S. House to represent Florida's 19th Congressional District. He declared candidacy for the 2026 election. Byron Donalds was born in Brooklyn, New York, and lives in Naples, Florida. Donalds earned a bachelor's degree in finance and marketing from Florida State University in 2002. His career experience includes working as a commercial credit officer in banking and as a portfolio manager in financial services.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.